Partnerships TV: Ira Spector, Allergan

At the 20th Annual Partnerships in Clinical Trials, Marc Dresner, the Communications Lead, Audience Engagement for the Partnerships in Clinical Trials Event, sat down with the outsourcing professionals who make the global clinical trials industry work.  We'll be profiling each of these interviews leading up to the 21st Annual Partnerships in Clinical Trials, taking place this March in Orlando.

Today's featured interview is with Ira Spector, Senior Vice President Global Development
Operations, Allergan Inc.  He discusses the emerging trends of outsourcing and addresses some of the concerns he has with outsourcing many of the core competencies to other companies.  He sees the core competencies of a drug company as discovery, development and production, but this is changing in the emerging model of the global outsourcing landscape.  Should companies be outsourcing all of these things to CROs?

Watch Partnerships TV for his answer:





At Partnerships in Clinical Trials 2012, we’ve put together a panel of clinical trial outsourcing leaders to address obstacles of partnering to significantly improve success rates for clinical trials. You’ll walk away with answers to your toughest questions on strategic partnering.  To see the outsourcing leaders who will be joining us, in addition to the rest of the program, download the brochure.  Also, as a Partnerships in Clinical Trials blog reader, mention code XP1700Blog to receive 15% off the standard rate!

Do you agree with Spector?  Why or why not?